RWB
BIO icon

RMR Wealth Builders’s Bio-Rad Laboratories Class A BIO Stock Holding History

RMR Wealth Builders’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-100
Closed -$57K – 233
2021
Q1 		$57K Hold
100
– – 0.01% 347
2020
Q4 		$58K Buy
+100
New +$57K 0.03% 242
2020
Q3 		– Sell
-100
Closed -$45K – 251
2020
Q2 		$45K Buy
+100
New +$44.1K 0.04% 235
2019
Q4 		$37K Buy
+100
New +$35.3K 0.04% 255

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

RMR Wealth Builders's BIO Position: Q2 2021 in Review

RMR Wealth Builders sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2021, closing a stake of 100 shares — an estimated $57K sold.

RMR Wealth Builders first reported a position in BIO in Q4 2019 and held it in 4 quarters. The position peaked at $58K in Q4 2020. 509 funds tracked by Wall St. Rank hold BIO as of Q2 2021.

  • RMR Wealth Builders reported no remaining Bio-Rad Laboratories Class A position as of Q2 2021 after selling out during the quarter.
  • RMR Wealth Builders sold 100 Bio-Rad Laboratories Class A shares in Q2 2021, an estimated $57K.
  • RMR Wealth Builders first reported a position in Bio-Rad Laboratories Class A in Q4 2019 and held it in 4 quarters.
  • RMR Wealth Builders's Bio-Rad Laboratories Class A position peaked at $58K in Q4 2020.
  • 509 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2021.

Based on RMR Wealth Builders's 13F filing for Q2 2021, filed 16 Aug 2021.